Professor Simon Finfer of The George Institute received an Honorary Doctorate from the Faculty of Medicine of the Friedrich Schiller University in Jena earlier this month.
Professor Finfer was awarded the Honorary Doctorate for his outstanding work as a clinician and researcher, said Professor Kondrad Reinhart, Director of Anesthesiology and Intensive Care Medicine at Friedrich Schiller University in Jena, who gave the Laudatory speech in honour of Professor Finfer.
Professor Elizabeth Elliott AM has been recognised as one of Australia's Women of Influence for her advocacy work in children's health and is among 100 women commended by The Australian Financial Review and Westpac for helping shape a bold and diverse future for Australia.
Australia's National Health and Medical Research Council has awarded The George Institute for Global Health $13 million for research in its 2013 round of grants. The selection of projects represents a cross section of The George Institute's research priorities and collaborations across Australia, China and India.
The George Institute and Peking University Health Science Center sign MOUAfter eight years of collaboration and friendship and two years of negotiations, The George Institute for Global Health and Peking University Health Science Center officially signed a Memorandum of Understanding (MOU) recently at the Peking University campus.
A landmark study by Australian and New Zealand researchers has found that a widely used starch fluid for resuscitation of patients in intensive care units (ICUs) provides no clinical benefit and its use results in increased acute kidney failure (haemodialysis) when compared to normal saline.
To screen for serious neck (cervical spine) injuries such as fractures in the emergency department, the Canadian Cervical Spine rule (C-Spine) appears to be more accurate compared with the National Emergency X-Radiography Utilisation Study (NEXUS) criteria, according to a review published today in the Canadian Medical Association Journal.
Professor Simon Finfer, of The George Institute for Global Health, led investigators in this second study, which provided an important new analysis of the Normoglycemia in Intensive Care Evaluation–Survival Using Glucose Algorithm Regulation (NICE SUGAR) trial data.
Despite and perhaps because of the advances in biomedicine over the past few decades, chronic diseases, like heart disease, stroke, and diabetes are now rising in many places of the world and more worryingly they impose their heaviest burden on the poor and disadvantaged populations.
In 2002, 3.5 million people died of cancer in Asia. This is expected to increase to 8.1 million by 2020. As the death rate and prevalence of cancer hits hard in Asia, specific concerns have been raised about the economic toll of the disease on patients and their families. Ongoing treatments are expensive and can impose a considerable financial burden.